计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| C413918-5mg |
5mg |
现货 ![]() |
| |
| C413918-10mg |
10mg |
现货 ![]() |
| |
| C413918-25mg |
25mg |
现货 ![]() |
| |
| C413918-50mg |
50mg |
现货 ![]() |
| |
| C413918-100mg |
100mg |
现货 ![]() |
|
| 别名 | 氯脒TFA |
|---|---|
| 规格或纯度 | ≥97% |
| 英文名称 | Cl-amidine TFA |
| 生化机理 | 氯脒是一种不可逆的泛肽基精氨酸脱氨酶(PAD)抑制剂,对 PAD4、PAD1 和 PAD3 的 IC50 值分别为 5.9 ± 0.3 μM、0.8 ± 0.3 μM、6.2 ± 1.0 μM。氯脒诱导细胞凋亡。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
Information Cl-amidine Cl-amidine is an irreversible pan- peptidylarginine deiminase (PAD) inhibitor with IC50 values of 5.9 ± 0.3 μM, 0.8 ± 0.3 μM, 6.2 ± 1.0 μM for PAD4, PAD1 and PAD3, respectively. Cl-amidine induces apoptosis . Targets PAD1 (Cell-free assay); PAD4 (Cell-free assay); PAD3 (Cell-free assay) 0.8 μM; 5.9 μM; 6.2 μM In vitro Cl-amidine antagonizes the PAD4-mediated enhancement of the the p300GBD-GRIP1 interaction in a dose-dependent manner. The inhibitory effect of this compound is not a nonspecific one but is targeted at the active PAD4 enzyme. Cl-amidine increases p53 expression in CD45 positive immune cells. It triggers the differentiation and apoptosis of multiple cancer cell lines that are p53+/+ and p53−/− (e.g., HL60, HT29, TK6, and U2-OS cells). Cl-amidine induces the expression of p53 and several downstream target genes including the cyclin dependent kinase inhibitor p21, GADD45, and the proapoptotic protein PUMA in U2-OS osteosarcoma cells. In vivo Cl-amidine treatment inhibits NZM(New Zealand mixed 2328) NET(neutrophil extracellular trap) formation in vivo and significantly alters circulating autoantibody profiles and complement levels while reducing glomerular IgG deposition. Further, Cl-amidine increases the differentiation capacity of bone marrow endothelial progenitor cells, improves endothelium-dependent vasorelaxation, and markedly delays time to arterial thrombosis induced by photochemical injury. Cl-amidine delays thrombosis development in NZM mice. It inhibits PADs in mice without significant toxicity and improves disease phenotypes in animal models of inflammatory arthritis and inflammatory bowel disease. And It is shown to reduce disease severity in mouse models of ulcerative colitis and RA. Cell Research(from reference) Cell lines:CV-1 cells Concentrations:0-200 μM Incubation Time:40 h |
| 纯度 | ≥97% |
| ALogP | 1.333 |
|---|---|
| hba_count | 3 |
| HBD Count | 3 |
| Rotatable Bond | 10 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | N-[(2S)-1-amino-5-[(1-amino-2-chloroethylidene)amino]-1-oxopentan-2-yl]benzamide;2,2,2-trifluoroacetic acid |
| INCHI | 1S/C14H19ClN4O2.C2HF3O2/c15-9-12(16)18-8-4-7-11(13(17)20)19-14(21)10-5-2-1-3-6-10;3-2(4,5)1(6)7/h1-3,5-6,11H,4,7-9H2,(H2,16,18)(H2,17,20)(H,19,21);(H,6,7)/t11-;/m0./s1 |
| InChi Key | WUSNMVYWOLUWDD-MERQFXBCSA-N |
| Smiles | C1=CC=C(C=C1)C(=O)NC(CCCN=C(CCl)N)C(=O)N.C(=O)(C(F)(F)F)O |
| Isomeric SMILES | C1=CC=C(C=C1)C(=O)N[C@@H](CCCN=C(CCl)N)C(=O)N.C(=O)(C(F)(F)F)O |
| 关联CAS | 1373232-26-8;913723-61-2 |
| 分子量 | 424.8 |
| 溶解性 | Solubility (25°C) In vitro DMSO: 84 mg/mL warmed with 50ºC Water: bath (197.74 mM); Ethanol: 84 mg/mL warmed with 50ºC Water: bath (197.74 mM); Water: 70 mg/mL warmed with 50ºC Water: bath (164.78 mM); |
|---|---|
| DMSO(mg / mL) Max Solubility | 84 |
| DMSO(mM) Max Solubility | 197.740113 |
| Water(mg / mL) Max Solubility | 70 |
| Water(mM) Max Solubility | 164.7834275 |
| 分子量 | 424.800 g/mol |
| XLogP3 | |
| 氢键供体数Hydrogen Bond Donor Count | 4 |
| 氢键受体数Hydrogen Bond Acceptor Count | 8 |
| 可旋转键计数Rotatable Bond Count | 8 |
| 精确质量Exact Mass | 424.113 Da |
| 单同位素质量Monoisotopic Mass | 424.113 Da |
| 拓扑极表面积Topological Polar Surface Area | 148.000 Ų |
| 重原子数Heavy Atom Count | 28 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 465.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 1 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 2 |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | C413918 | |
| 分析证书 | C413918 | |
| 分析证书 | C413918 | |
| 分析证书 | C413918 | |
| 分析证书 | C413918 | |
| 分析证书 | C413918 | |
| 分析证书 | C413918 | |
| 分析证书 | C413918 | |
| 分析证书 | C413918 | |
| 分析证书 | C413918 | |
| 分析证书 | C413918 | |
| 分析证书 | C413918 |
¥1,455.92